U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07531511) titled 'SLC6A1-NDD Prospective Longitudinal Natural History Study' on April 08.
Brief Summary: The overall objective of this prospective longitudinal natural history study is to collect clinical data to characterize and evaluate the natural course of SLC6A1-NDD and assess the feasibility of certain assessments for the purpose of conducting future clinical studies in patients with this disease.
Study Start Date: April, 2026
Study Type: OBSERVATIONAL
Condition:
SLC6A1 Neurodevelopmental Disorder (NDD)
Developmental and Epileptic Encephalopathies
Recruitment Status: NOT_YET_RECRUITING
Sponsor: UCB Biopharma SRL
Disclaimer: Curated by H...